LYNX1 CAPITAL MANAGEMENT LP – Pieris Pharmaceuticals, Inc. Transaction History
LYNX1 CAPITAL MANAGEMENT LP portfolio value:
$4.04M
portfolio value
LYNX1 CAPITAL MANAGEMENT LP quarter portfolio value change:
-38.50%
quarter
Pieris Pharmaceuticals, Inc. 13F transactions
| Quarter | Transaction type | Change | Relative change | Absolute change | Change value | Avg. price | Shares |
|---|---|---|---|---|---|---|---|
| Q3 2022 | share | Increase | +9.05% | 291.80K shares | -1.98M | $1.15 | 3.51M |
| Q2 2022 | share | Increase | +183.66% | 2.08M shares | 2.58M | $1.87 | 3.22M |
| Q1 2022 | share | Increase | +196.48% | 753.05K shares | 1.99M | $3.03 | 1.13M |
| Q4 2021 | share | Increase | 0.00% | 383.26K shares | 1.44M | $3.94 | 383.26K |